Earl Martin Douglas

ALLO

Earl Martin Douglas serves as SVP, General Counsel at Allogene Therapeutics, Inc. (ALLO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$130.1K

Net Position

Net Seller

$130.1K

Companies Traded

ALLO

Active Period

Aug 2024 – Feb 2026

3 total trades

Most Recent

Sell ALLO

Feb 2, 2026 · $40.3K

Earl Martin Douglas's Insider Trading at Allogene Therapeutics, Inc. (ALLO)

Buys

0 · $0.00

Sells

3 · $130.1K

Total Shares Bought

Total Shares Sold

57,614

ALLO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 2, 2026	Sell	22,900	$1.76	$40.3K
Feb 3, 2025	Sell	6,404	$1.71	$11.0K
Aug 21, 2024	Sell	28,310	$2.79	$78.8K

Related Insiders

Annie Yoshiyama

SVP, Finance

ALLOSell · Apr 23, 2026

Benjamin Machinas Beneski

SVP, Chief Technical Officer

ALLOSell · Apr 2, 2026

David D Chang

President and CEO

ALLOSell · Mar 18, 2026

Geoffrey M. Parker

CHIEF FINANCIAL OFFICER

ALLOSell · Feb 2, 2026

Zachary Roberts

EVP of R&D

ALLOSell · Feb 2, 2026

MESSEMER DEBORAH M.

Director

ALLOSell · Jun 10, 2025

Explore More Insider Trading Data

ALLO Insider Trading Activity

View all insider trades at Allogene Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity